Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
6.58
-0.12 (-1.79%)
Aug 1, 2025, 4:00 PM - Market closed
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $10.52 million as of August 1, 2025. Its market cap has decreased by -43.68% in one year.
Market Cap
10.52M
Enterprise Value
12.14M
1-Year Change
-43.68%
Ranking
Category
Stock Price
$6.58
Market Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from $230.14M to $10.52M, a decrease of -95.43%. That is a compound annual growth rate of -44.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 10.52M | -22.15% |
| Dec 31, 2024 | 13.51M | -95.09% |
| Dec 29, 2023 | 275.43M | 175.60% |
| Dec 30, 2022 | 99.94M | 76.26% |
| Dec 31, 2021 | 56.70M | -61.52% |
| Dec 31, 2020 | 147.37M | -35.97% |
| May 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.79B |
| Johnson & Johnson | 397.79B |
| AbbVie | 340.58B |
| AstraZeneca | 232.21B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.40B |
| UnitedHealth Group | 218.51B |
| Novo Nordisk | 213.92B |